These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 24650035

  • 1. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
    Piao J, Shang Y, Liu S, Piao Y, Cui X, Li Y, Lin Z.
    Diagn Pathol; 2014 Mar 20; 9():67. PubMed ID: 24650035
    [Abstract] [Full Text] [Related]

  • 2. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
    Lin L, Piao J, Gao W, Piao Y, Jin G, Ma Y, Li J, Lin Z.
    BMC Cancer; 2013 Jul 31; 13():366. PubMed ID: 23902796
    [Abstract] [Full Text] [Related]

  • 3. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
    Wang X, Lin L, Ren X, Lin Z, Li Z, Li C, Jin T.
    Int J Clin Exp Pathol; 2014 Jul 31; 7(8):5016-23. PubMed ID: 25197373
    [Abstract] [Full Text] [Related]

  • 4. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.
    Jin J, Jin T, Quan M, Piao Y, Lin Z.
    Diagn Pathol; 2012 Oct 05; 7():135. PubMed ID: 23039327
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
    Sun L, Chen F, Shi W, Qi L, Zhao Z, Zhang J.
    Diagn Pathol; 2014 Jul 16; 9():125. PubMed ID: 25029906
    [Abstract] [Full Text] [Related]

  • 6. DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.
    Lee KF, Tsai MM, Tsai CY, Huang CG, Ou YH, Hsieh CC, Hsieh HL, Wang CS, Lin KH.
    Int J Mol Sci; 2019 Nov 13; 20(22):. PubMed ID: 31766266
    [Abstract] [Full Text] [Related]

  • 7. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J, Bi F, Yang Y, Zhang Y, Jin A, Li J, Lin Z.
    Oncol Rep; 2017 Feb 13; 37(2):857-864. PubMed ID: 27959420
    [Abstract] [Full Text] [Related]

  • 8. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
    Wang J, Shen H, Fu G, Zhao D, Wang W.
    Oncotarget; 2017 Feb 07; 8(6):9442-9450. PubMed ID: 28038462
    [Abstract] [Full Text] [Related]

  • 9. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X, Qi D, Qi J, Mao Z, Li X, Zhang J, Li J, Gao W.
    Oncol Rep; 2016 Jan 07; 35(1):155-62. PubMed ID: 26530274
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C, Gao X, Liu H, Jiang T, Zhai X.
    Int J Clin Exp Pathol; 2014 Jan 07; 7(8):4782-94. PubMed ID: 25197349
    [Abstract] [Full Text] [Related]

  • 11. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
    Lee SY, Jung W, Lee J, Kim A, Kim HK, Kim BH.
    Histol Histopathol; 2019 Nov 07; 34(11):1279-1288. PubMed ID: 31066459
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.
    Oncol Rep; 2012 Jan 07; 27(1):135-42. PubMed ID: 21947329
    [Abstract] [Full Text] [Related]

  • 13. [HBXIP expression in gastric adenocarcinoma predicts poor prognosis].
    Piao JJ, Li N, Wang YX, Lin ZH, Liu SP.
    Zhonghua Bing Li Xue Za Zhi; 2017 Feb 08; 46(2):88-92. PubMed ID: 28173666
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological correlation and prognostic significance of sonic hedgehog protein overexpression in human gastric cancer.
    Niu Y, Li F, Tang B, Shi Y, Hao Y, Yu P.
    Int J Clin Exp Pathol; 2014 Feb 08; 7(8):5144-53. PubMed ID: 25197388
    [Abstract] [Full Text] [Related]

  • 15. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
    Lv H, Cui A, Sun F, Zhang Y, Li Y, Li L, Lin Z.
    Exp Mol Pathol; 2014 Aug 08; 97(1):74-80. PubMed ID: 24866365
    [Abstract] [Full Text] [Related]

  • 16. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Martinez-Useros J, Moreno I, Fernandez-Aceñero MJ, Rodriguez-Remirez M, Borrero-Palacios A, Cebrian A, Gomez Del Pulgar T, Del Puerto-Nevado L, Li W, Puime-Otin A, Perez N, Soengas MS, Garcia-Foncillas J.
    BMC Cancer; 2018 Feb 06; 18(1):144. PubMed ID: 29409457
    [Abstract] [Full Text] [Related]

  • 17. Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer.
    Gao C, Ma T, Pang L, Xie R.
    Diagn Pathol; 2014 Mar 12; 9():55. PubMed ID: 24621074
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
    Han S, Xuan Y, Liu S, Zhang M, Jin D, Jin R, Lin Z.
    Pathol Int; 2009 Jul 12; 59(7):443-7. PubMed ID: 19563407
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma.
    Ou Y, Xia R, Kong F, Zhang X, Yu S, Jiang L, Zheng L, Lin L.
    Oncol Lett; 2016 Mar 12; 11(3):1823-1828. PubMed ID: 26998084
    [Abstract] [Full Text] [Related]

  • 20. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
    Suh JH, Won KY, Kim GY, Bae GE, Lim SJ, Sung JY, Park YK, Kim YW, Lee J.
    Int J Clin Exp Pathol; 2015 Mar 12; 8(11):14608-18. PubMed ID: 26823784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.